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Abstract
Background: Near-Infrared (NIR) intraoperative molecular imaging is a new diagnostic modality utilized during
cancer surgery for the identification of tumors, metastases and lymph nodes. Surgeons typically use headlamps
during an operation to increase visible light; however, these light sources are not adapted to function simultaneously
with NIR molecular imaging technology. Here, we design a NIR cancelling headlamp and utilize it during surgery to
assess whether intraoperative molecular imaging of mediastinal tumors is possible.
Methods: A NIR cancelling headlamp was designed and tested using NIR spectroscopy preoperatively. Next, a
46 year-old-female was referred to the thoracic surgery clinic for a 5.8 cm mediastinal mass noted on chest
x-ray. Prior to surgery, she was given intravenous indocyanine green (ICG). Then, the prototype headlamp was
used in conjunction with our intraoperative molecular imaging device. The tumor was imaged both in vivo
and following resection prior to pathological examination.
Results: NIR spectroscopy confirmed NIR light excitation of the unfiltered headlamp and the absence of NIR
emitted light after addition of the filter. Next, in vivo imaging confirmed fluorescence of the tumor, but also
demonstrated a significant amount of NIR background fluorescence emanating from the unfiltered headlamp.
During imaging with the filtered headlamp, we again demonstrated a markedly fluorescent tumor but with a
reduced false positive NIR signal. Final pathology was well-differentiated thymoma with negative surgical margins.
Conclusions: NIR intraoperative molecular imaging using a systemic injection of intravenous ICG was successful in
localizing a thymoma. Additionally, a simple design and implementation of a NIR cancelling headlamp reduces false
positive NIR fluorescence.
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Background
Near-infrared (NIR) intraoperative molecular imaging is
utilized for cancer surgery for the detection of many
tumor types, including colorectal, ovarian and lung can-
cers [1–6]. The most commonly used and only FDA ap-
proved NIR tracer for cancer detection is indocyanine
green (ICG). Benefits of NIR imaging include the use of
non-ionizing radiation as the NIR spectrum involves low
energy light ranging from 750 to 1400 nm [7].
During open surgery, surgeons frequently use over-
the-bed operating room lights and headlamps to provide
additional visible light to the surgical field. These lights
can be problematic for intraoperative imaging because
they emit NIR light in addition to white light that results
in a false positive signal [8]. We developed and tested a
novel headlamp system that filters out this false positive
NIR signal without affecting intraoperative visibility or
significantly altering the weight or utility of the head-
lamp. This approach allows a surgeon to perform a rou-
tine cancer operation without compromising his or her
view while obtaining the optimal NIR excitation and
visualization for cancer imaging.* Correspondence: janejkeating@gmail.comDepartment of Surgery, University of Pennsylvania and Philadelphia VA
Medical Center, 6 White Building, 3400 Spruce Street, Philadelphia, PA 19104,
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To create the NIR cancelling headlamp, an UltraLite
Plus Headlight System (Integra, AX1375BIF) was fitted
with two sequential 25 mm diameter heat absorbing
glass filters (Edmund Optics, #49-088). The IR-Cut fil-
ters were placed sequentially to allow visible spectral
range light to pass while strongly blocking infrared rays
from 780 nm and higher. Each filter is 3 mm thick and
able to stand up to 300° Celsius. Thus, they are able to
withstand the heat generated by headlamps over the
complete duration of a surgery. Together the filters
weigh approximately 70 g, so they add negligible weight
to the headlamp. All construction was performed by the
Research Instrumentation Shop at the Perelman School
of Medicine at the University of Pennsylvania.
Spectroscopy
The headlamp without any filtration was first tested
using an Ocean Optics spectrometer (QE65 Pro). This
spectrometer consists of a full frame transfer charge
coupled device (FFT-CCD) image sensor that can detect
signal from 200 to 1100 nm. Headlamp emission was
measured by the spectrometer both with and without
the filter for comparison. The conditions under which
spectroscopy was performed were kept identical before
and after removal of the filter. The spectrometer was
held as fixed and close to the illuminated headlamp as
possible without touching the surface. Additionally the
level of ambient light was held constant throughout the
entirety of the experiment.
Patient
A 46 year-old-female was enrolled for intraoperative im-
aging in a thoracic surgery clinic for an incidentally dis-
covered mediastinal mass on chest x-ray. The mass was
noted to be 5.8 cm on preoperative CT scan (Fig. 1).
Following informed and written consent, the patient was
enrolled in a clinical trial studying NIR intraoperative
molecular imaging of mediastinal tumors. The clinical
trial protocol was approved by the University of Pennsyl-
vania Institutional Review Board.
Twenty-four hours prior to surgery, the patient under-
went intravenous injection of 5 mg/kg of indocyanine
green (ICG) via antecubital vein.
Reagent
Indocyanine green (ICG) (Akorn, Lake Forest, IL and
Pulsion, Feldkirchen, Germany) is a water-soluble an-
ionic, amphiphilic NIR fluorophore with an excitation
wavelength of 790 nm and an emission wavelength of
830 nm and a molecular weight of 774.9 kDA.
Imaging device
Macroscopic surgical fluorescent imaging was performed
using the Iridium (Visionsense, New York, NY) which is
capable of emitting and absorbing light in the NIR
spectrum. The Iridium is a high definition (HD) 3D
camera (λex 790 nm and λem 830 nm). Positive and
negative controls were used for all images. The imaging
device was held 10 in. above the specimen for each
measurement for consistency of focal length.
Tumor-to-background ratio
We used region-of-interest software and HeatMap plu-
gin within ImageJ (http://rsb.info.nih.gov/ij/; public do-
main free software developed by National Institutes of
Health) in order to quantitate tissue fluorescence. The
NIR fluorescence of the tumor and surrounding normal
mediastinal subcutaneous fat in vivo were measured in
order to calculate a mean tumor-to-background ratio
(TBR). Four total measurements of both tumor and
background fluorescence were recorded. The first meas-
urement was taken at the approximated center of the
tumor. The following three measurements were taken
1 cm from the centimeter of the tumor in three radial
directions (12 o’clock, 4 o’clock and 8 o’clock). These
four measurements were used to calculate mean tumor
fluorescence. Similarly, background fluorescence was
measured from surrounding subcutaneous mediastinal
fat in four radial directions extending from the center of
the tumor (superior, inferior, medial and lateral). The
mean background fluorescence was then calculated, and
mean fluorescence from both the tumor and surround-
ing background were used to generate a mean TBR. An
identical technique was used for ex vivo TBR measure-
ment. For ex vivo imaging, the background fluorescence
was taken from a non-reflective blue cloth background.
Fig. 1 Preoperative CT scan of the chest. Incidentally discovered
5.8 cm anterior mediastinal mass noted on preoperative CT scan.
The arrow points to the tumor
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Results
NIR spectroscopy of filtered headlamp detects deleted
NIR emission
The headlamp was configured in order to allow ease of
filter application and removal (Fig. 2). First, headlamp
emission without any filtration was measured by the
spectrometer, which confirmed light excitation greater
than 780 nm (Fig. 3a) that falls within the NIR range.
This falls within the detectable range of our imaging de-
vice and causes false positive fluorescence during im-
aging. With the addition of the NIR cancelling filter,
spectroscopy was repeated, which showed no light emit-
ted above 780 nm within the NIR spectrum (Fig. 3b).
Filtered headlamp reduces in vivo false positive NIR
fluorescence
Twenty-four hours after ICG injection, the patient was
brought to the operating room. Following standard
anesthesia, intubation and sternotomy, the tumor was
localized, the overhead lights were dimmed, and our
NIR imaging device was draped and suspended above
the patient. At this time, the surgeon was wearing the
standard unfiltered headlamp. In vivo imaging confirmed
fluorescence of the tumor but also demonstrated a sig-
nificant amount of NIR background fluorescence eman-
ating from the headlamp. The surgeon’s headlamp was
replaced with the modified prototype headlamp and the
surgical bed was re-imaged.
Both in vivo and ex vivo imaging of the mediastinal
mass again demonstrated a markedly fluorescent tumor
without the additional NIR fluorescence from the head-
lamp (Fig. 4). Mean in vivo tumor fluorescence without
headlamp filtration was noted to be 104.3 A.U. (+/- 4.0)
while background fluorescence was 63.7 A.U. (+/- 1.7).
The mean TBR was 1.6. Mean in vivo tumor
fluorescence with headlamp filtration was 107.0 A.U.
(+/- 3.6), mean background fluorescence was reduced to
35.4 A.U. (+/- 2.0), and mean TBR was 3.0. In other
words, with the addition of the filtered headlamp, there
was little difference between tumor fluorescence, how-
ever background fluorescence was significantly de-
creased which allowed for increased TBR. During
ex vivo imaging with the filtered headlamp still in place,
mean tumor fluorescence was 116.5 A.U. (+/- 6.4), mean
background fluorescence was 30.3 A.U. (+/- 1.7), and
mean TBR was 3.8. Final pathology of the mediastinal
tumor demonstrated thymoma with negative margins.
Discussion
NIR intraoperative molecular imaging using systemic
ICG successfully located a mediastinal tumor. Intraoper-
ative molecular imaging is a burgeoning area of technol-
ogy and research that has promising applications for
surgical oncology. With its increasing popularity, operat-
ing rooms around the country are being built specifically
with the capability of convenient housing of intraopera-
tive imaging devices [9–11]. However, troubleshooting is
still necessary in many instances. One area of improve-
ment is the reduction of false-positive NIR signal from
operating room lights and headlamps.
Here we describe the successful implementation of a
prototype headlamp for the removal of NIR signal from
a standard surgical headlamp. We first confirm pre-
operatively NIR subtraction using spectroscopy and then
show its utility in the operating room during intraopera-
tive molecular imaging of a mediastinal mass.
As NIR intraoperative molecular imaging is becoming in-
creasingly utilized, simple adjustments like the one we have
described are necessary for the successful and practical
implementation of this imaging technology. Additionally, in
Fig. 2 Headlamp with and without NIR cancelling filter. Typical surgical headlamp with and without the addition of a removable filter that
functions to cancel NIR light emitted from the headlamp onto the surgical field
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the future it is likely that the producers of surgical lights
and headlamps will be encouraged to permanently remove
the NIR signal emitted from standard operating room de-
vices as this signal provides no additional visibility to the
surgeon but instead causes distracting false positive signal
during these procedures. Based on our results with NIR in-
traoperative molecular imaging on a series of patients, a
larger clinical trial of NIR intraoperative molecular imaging
for mediastinal tumors is underway.
Conclusions
The addition of NIR-cancelling glass filters to a surgical
headlamp decreased background fluorescence during
intraoperative molecular imaging of a thymoma. This
Fig. 3 NIR Spectroscopy. a Spectroscopy demonstrating NIR light (780-950 nm) emitted from the surgical headlamp prior to addition of the filter.
b Spectroscopy shows absence of light greater than 780 nm after addition of the filter to the headlamp
Fig. 4 NIR Imaging of mediastinal mass in vivo and ex vivo. First row: In vivo NIR intraoperative molecular imaging with the use of a typical surgical
headlamp. White light, NIR fluorescence and overlay images are shown. Note the false positive NIR fluorescence detected with our intraoperative
imaging device when the headlamp is used without a filter. Second row: The addition of the NIR cancelling filter removes the NIR signal emitted from
the headlamp and thus reduces false positive fluorescence. Note the tumor is markedly fluorescent in vivo. Third row: With the filtered headlamp still
in place, the fluorescent tumor is reimaged ex vivo. Pathology demonstrated thymoma with negative surgical margins
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simple modification may improve localization and intra-
operative margin assessment during open oncology sur-
gery utilizing intraoperative molecular imaging.
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